… So, we can conclude that curcumin with anti-inflammatory properties and inhibition of PAK1, AP1 and NF-κB that create an inflammation status could be a potentially beneficial treatment …
CITATION STYLE
Nemati, M., Asl, E., Pouya, F., & Rasmi, Y. (2020). Curcumin, an Inhibitor of PAK1, Potential Treatment for COVID-19. Journal of Infectiology, 3(2), 1–3. https://doi.org/10.29245/2689-9981/2020/2.1160
Mendeley helps you to discover research relevant for your work.